U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07421427) titled 'Adding Amantadine or Duloxetine to Pregabalin on Occurrence of Post Mastectomy Pain Syndrome' on Feb. 12.
Brief Summary: This study aims to evaluate the additive effect of Amantadine or Duloxetine to Pregabalin on development of post mastectomy pain syndrome
Study Start Date: Feb. 20
Study Type: INTERVENTIONAL
Condition:
Amantadine
Duloxetine
Pregabalin
Mastectomy
Pain Syndrome
Intervention:
DRUG: Pregabalin
Two hours preoperative patient will receive one capsule of Pregabalin 75 mg (Lyrica 75 mg, Viatris) and) and one placebo tablet and will continue on both of them twice daily for seven days postoperative
DRUG: Pregabalin ...